Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × futibatinib × Clear all

Phase

Phase 2 5 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Biliary Tract Neoplasms 1

Interventions

Cisplatin 241 Radiotherapy 200 Fluorouracil 171 Cyclophosphamide 165 Capecitabine 163 Docetaxel 146 Oxaliplatin 138 Gemcitabine 133 Carboplatin 130 Paclitaxel 128 Dexamethasone 109 Leucovorin 101 Drug Therapy 101 Doxorubicin 99 Etoposide 83 Cytarabine 75 Bevacizumab 75 Vincristine 71 Irinotecan 65 Rituximab 64 Epirubicin 63 Methotrexate 54 Prednisone 53 Radiosurgery 52 Surgical Procedures, Operative 50 Radiotherapy, Intensity-Modulated 49 Radiation 49 Neoadjuvant Therapy 48 Lenalidomide 48 Chemotherapy, Adjuvant 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05615818 2025-04-23

SAFIR-ABC10

UNICANCER

Phase 3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡